BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30026865)

  • 1. A novel HPV16 E7-affitoxin for targeted therapy of HPV16-induced human cervical cancer.
    Jiang P; Wang L; Hou B; Zhu J; Zhou M; Jiang J; Wang L; Chen S; Zhu S; Chen J; Zhang L
    Theranostics; 2018; 8(13):3544-3558. PubMed ID: 30026865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted biological effect of an affitoxin composed of an HPV16E7 affibody fused with granzyme B (ZHPV16E7-GrB) against cervical cancer in vitro and in vivo.
    Wang W; Tan X; Jiang J; Cai Y; Feng F; Zhang L; Li W
    Curr Cancer Drug Targets; 2020 Dec; ():. PubMed ID: 33292132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bispecific affibody molecule targeting HPV16 and HPV18E7 oncoproteins for enhanced molecular imaging of cervical cancer.
    Zhu S; Zhu J; Song Y; Chen J; Wang L; Zhou M; Jiang P; Li W; Xue X; Zhao KN; Zhang L
    Appl Microbiol Biotechnol; 2018 Sep; 102(17):7429-7439. PubMed ID: 29938318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of affibody molecules specific for HPV16 E7 recognition.
    Xue X; Wang B; Du W; Zhang C; Song Y; Cai Y; Cen D; Wang L; Xiong Y; Jiang P; Zhu S; Zhao KN; Zhang L
    Oncotarget; 2016 Nov; 7(45):73995-74005. PubMed ID: 27659535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high-risk papillomavirus 18 E7 affibody-enabled in vivo imaging and targeted therapy of cervical cancer.
    Wang L; Du W; Zhu S; Jiang P; Zhang L
    Appl Microbiol Biotechnol; 2019 Apr; 103(7):3049-3059. PubMed ID: 30770966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective targeting of HPV-16 E6/E7 in cervical cancer cells with a potent oncolytic adenovirus and its enhanced effect with radiotherapy in vitro and vivo.
    Wang W; Sima N; Kong D; Luo A; Gao Q; Liao S; Li W; Han L; Wang J; Wang S; Lu Y; Wang D; Xu G; Zhou J; Meng L; Ma D
    Cancer Lett; 2010 May; 291(1):67-75. PubMed ID: 19903581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
    Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H
    Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel, broad spectrum therapeutic HPV vaccine targeting the E7 proteins of HPV16, 18, 31, 45 and 52 that elicits potent E7-specific CD8T cell immunity and regression of large, established, E7-expressing TC-1 tumors.
    Wick DA; Webb JR
    Vaccine; 2011 Oct; 29(44):7857-66. PubMed ID: 21816200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo antitumor effect of an intracellular single-chain antibody fragment against the E7 oncoprotein of human papillomavirus 16.
    Accardi L; Paolini F; Mandarino A; Percario Z; Di Bonito P; Di Carlo V; Affabris E; Giorgi C; Amici C; Venuti A
    Int J Cancer; 2014 Jun; 134(11):2742-7. PubMed ID: 24226851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination of full-length HPV16 E6 or E7 protein inhibits the growth of HPV16 associated tumors.
    Li YL; Qiu XH; Shen C; Liu JN; Zhang J
    Oncol Rep; 2010 Nov; 24(5):1323-9. PubMed ID: 20878127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanobody against the E7 oncoprotein of human papillomavirus 16.
    Li S; Zhang W; Jiang K; Shan H; Shi M; Chen B; Hua Z
    Mol Immunol; 2019 May; 109():12-19. PubMed ID: 30849663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation, Characterization and Diagnostic Valuation of Two Novel Anti-HPV16 E7 Oncoprotein Monoclonal Antibodies.
    Hu R; Dong Z; Zhang K; Pan G; Li C; Cui H
    Viruses; 2020 Mar; 12(3):. PubMed ID: 32204370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy of a human papillomavirus type 16 E7-expressing tumor by administration of fusion protein comprised of Mycobacterium bovis BCG Hsp65 and HPV16 E7.
    Chu NR; Wu HB; Wu TC; Boux LJ; Mizzen LA; Siegel MI
    Cell Stress Chaperones; 2000 Nov; 5(5):401-5. PubMed ID: 11189443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Papillomavirus E6/E7-Specific siRNA Potentiates the Effect of Radiotherapy for Cervical Cancer in Vitro and in Vivo.
    Jung HS; Rajasekaran N; Song SY; Kim YD; Hong S; Choi HJ; Kim YS; Choi JS; Choi YL; Shin YK
    Int J Mol Sci; 2015 May; 16(6):12243-60. PubMed ID: 26035754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant growth inhibition by a bispecific affibody targeting oncoprotein E7 in both HPV16 and 18 positive cervical cancer in vitro and in vivo.
    Tan X; Yang J; Jiang J; Wang W; Ren J; Li Q; Xie Z; Chen X; Zhang L; Li W
    Eur J Pharm Sci; 2022 May; 172():106156. PubMed ID: 35245683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis induced by an antagonist peptide against HPV16 E7 in vitro and in vivo via restoration of p53.
    Guo C; Liu K; Zheng Y; Luo H; Chen H; Huang L
    Apoptosis; 2011 Jun; 16(6):606-18. PubMed ID: 21475994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention against head and neck cancer-containing HPV16 cell lines.
    Adhim Z; Otsuki N; Kitamoto J; Morishita N; Kawabata M; Shirakawa T; Nibu K
    Acta Otolaryngol; 2013 Jul; 133(7):761-71. PubMed ID: 23638950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular expression of a single-chain antibody directed against human papillomavirus type 16 E7 oncoprotein achieves targeted antineoplastic effects.
    Wang-Johanning F; Gillespie GY; Grim J; Rancourt C; Alvarez RD; Siegal GP; Curiel DT
    Cancer Res; 1998 May; 58(9):1893-900. PubMed ID: 9581830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological protection against HPV16 E7-expressing human esophageal cancer cell challenge by a novel HPV16-E6/E7 fusion protein based-vaccine in a Hu-PBL-SCID mouse model.
    Lu Y; Zhang Z; Liu Q; Liu B; Song X; Wang M; Zhao X; Zhao Q
    Biol Pharm Bull; 2007 Jan; 30(1):150-6. PubMed ID: 17202676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
    Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
    Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.